| Document Date: 2014-10-01 21:56:23
Open Document File Size: 166,34 KBShare Result on Facebook
City Copenhagen / / Company 15 New England Journal / New England Journal / Australia In / Boehringer Ingelheim Pty Ltd / ITT / / Country Australia / / Currency USD / / EntertainmentAwardEvent BAFTA / / Event Judicial Event / FDA Phase / / Holiday Commonwealth Day / / IndustryTerm stroke prevention / telephone requests / prevention of stroke / / MedicalCondition Previous stroke / Proposed Therapy Atrial fibrillation / arrhythmia / II WASPO Rash A / chronic atrial fibrillation / Hypertension / ventricular dysfunction / Non-haemorrhagic stroke / stroke/systemic embolism / systemic embolism / ischemic stroke / systemic thromboembolism / haemorrhagic stroke / stroke / thromboembolism / Diabetes / cardiac arrhythmia / CV death Non-haemorrhagic stroke / renal insufficiency / particularly ischaemic stroke / non-valvular atrial fibrillation / Heart failure / venous thromboembolism / ischaemic stroke / coronary artery disease / PE=pulmonary embolism / MI=myocardial infarction / atrial fibrillation / thrombus / SEE=systemic embolism / / MedicalTreatment knee replacement / orthopaedic surgery / hip replacement / total knee replacement / / Organization National Prescribing Service / Medicare / / Person Bing Za Zhi / Xin Xue / LY BI / Lloyd Sansom / / Position editor / Governor / model / Minister / nurse / Trial ID/First Protocol title/ Publication title author / Professor / / Product Irbesartan / clopidogrel / Dabigatran / / PublishedMedium New England Journal of Medicine / Archives of Internal Medicine / / URL http /
SocialTag |
Microsoft WordDabigatran Boehringer-Ingelheim PSD FINAL.docx